1. Home
  2. DBVT vs EVTL Comparison

DBVT vs EVTL Comparison

Compare DBVT & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • EVTL
  • Stock Information
  • Founded
  • DBVT 2002
  • EVTL 2016
  • Country
  • DBVT France
  • EVTL United Kingdom
  • Employees
  • DBVT N/A
  • EVTL N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • EVTL Aerospace
  • Sector
  • DBVT Health Care
  • EVTL Industrials
  • Exchange
  • DBVT Nasdaq
  • EVTL Nasdaq
  • Market Cap
  • DBVT 464.0M
  • EVTL 542.9M
  • IPO Year
  • DBVT N/A
  • EVTL N/A
  • Fundamental
  • Price
  • DBVT $14.36
  • EVTL $4.25
  • Analyst Decision
  • DBVT Buy
  • EVTL Strong Buy
  • Analyst Count
  • DBVT 5
  • EVTL 8
  • Target Price
  • DBVT $15.85
  • EVTL $11.43
  • AVG Volume (30 Days)
  • DBVT 172.8K
  • EVTL 1.7M
  • Earning Date
  • DBVT 10-28-2025
  • EVTL 08-05-2025
  • Dividend Yield
  • DBVT N/A
  • EVTL N/A
  • EPS Growth
  • DBVT N/A
  • EVTL N/A
  • EPS
  • DBVT N/A
  • EVTL N/A
  • Revenue
  • DBVT $5,502,000.00
  • EVTL N/A
  • Revenue This Year
  • DBVT $1,743.46
  • EVTL N/A
  • Revenue Next Year
  • DBVT $1,044.34
  • EVTL N/A
  • P/E Ratio
  • DBVT N/A
  • EVTL N/A
  • Revenue Growth
  • DBVT N/A
  • EVTL N/A
  • 52 Week Low
  • DBVT $2.21
  • EVTL $2.76
  • 52 Week High
  • DBVT $18.00
  • EVTL $15.99
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 51.23
  • EVTL 36.06
  • Support Level
  • DBVT $13.70
  • EVTL $4.19
  • Resistance Level
  • DBVT $15.97
  • EVTL $4.62
  • Average True Range (ATR)
  • DBVT 1.06
  • EVTL 0.28
  • MACD
  • DBVT -0.40
  • EVTL -0.06
  • Stochastic Oscillator
  • DBVT 15.71
  • EVTL 4.63

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: